House lawmakers are scheduled to vote Tuesday on a new version of the Right to Try Act that would allow terminally ill patients with no other treatment options access to experimental drugs that have undergone early-stage clinical trials. The bill, unveiled Saturday, would let patients request access to experimental drugs, but it won't require drugmakers to supply the treatments.
House to consider new version of "right-to-try" measure
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.